| James Martin, MD | |
|
100 E Carroll St, Salisbury, MD 21801-5422 | |
| (410) 749-1282 | |
| (410) 749-7821 |
| Full Name | James Martin |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Hematology & Oncology |
| Location | 100 E Carroll St, Salisbury, Maryland |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104896505 | NPI | - | NPPES |
| 362501000 | Medicaid | MD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | D30690 (Maryland) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| James Martin, MD 100 E Carroll St, Salisbury, MD 21801-5422 Ph: (410) 749-1282 | James Martin, MD 100 E Carroll St, Salisbury, MD 21801-5422 Ph: (410) 749-1282 |
News Archive
ReCor Medical, an emerging medical device company, reported today six-month follow-up data on eight patients who have been treated via renal denervation for their resistant hypertension with the Company's PARADISE System—the only system for renal denervation that is based on ultrasound, not radiofrequency, energy.
Lakewood-Amedex, a leading developer of novel anti-infective pharmaceuticals, announced today that the United States Patent and Trademark Office has issued Notice of Allowances on three patent applications relating to the use of novel monoclonal antibodies for the treatment of hemolytic uremic syndrome caused by shiga toxin II secreting E.coli O157: H7 strain.
Serious falls are more than twice as likely in older men who take medicines with anti-cholinergic properties - according to new research from the University of East Anglia.
An intervention to connect low-income uninsured and Medicaid patients to a reliable source of primary health care shows promise for reducing avoidable use of hospital emergency departments in Maryland. A University of Maryland School of Public Health study evaluating the results of the intervention was published this week in the May issue of the journal Health Affairs.
Use of certain antidepressants, selective serotonin-reuptake inhibitors most commonly known as SSRIs, during pregnancy does not significantly increase the risk for most birth defects, according to a new Centers for Disease Control and Prevention (CDC) study, released in the New England Journal of Medicine (NEJM).
› Verified 8 days ago
Leslie Michelle Belloso, M.D. Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 3911 Devonshire Dr, Salisbury, MD 21804 Phone: 410-548-4514 | |
Charles B Silvia Jr., MD Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 100 E Carroll St, Inpatient Services, Salisbury, MD 21801 Phone: 410-543-7536 Fax: 410-543-7272 | |
Dr. Curtis Harris Jr., M.D. Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 224 Phillip Morris Dr, Salisbury, MD 21804 Phone: 410-831-3174 Fax: 410-630-5379 | |
Jack L Snitzer, DO Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1415 S Division St, Suite A, Salisbury, MD 21804 Phone: 410-572-8848 | |
Sharad R Satyal, M. D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 910 Eastern Shore Dr, Salisbury, MD 21804 Phone: 410-546-1331 Fax: 410-543-8107 | |
Dr. Hameem I Kawsar, MD., PH.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 100 E Carroll St, Salisbury, MD 21801 Phone: 410-546-6400 | |
Dr. Michael B Hess, D.O. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 100 E Carroll St, Salisbury, MD 21801 Phone: 410-546-6400 Fax: 225-765-9196 |